Research
Epitranscriptomics & Cancer Adaptation : A.David

Activities

Our research work focuses on the contribution of post-transcriptional mechanisms on cancer cell adaptation, in particular RNA epigenetic & translational control.

More..

Zotero public

Added by Nathalie Bonnefoy
Group name EquipeNB
Item Type Journal Article
Title Feasibility of accelerated partial breast irradiation with volumetric-modulated arc therapy in elderly and frail patients
Creator Riou et al.
Author Olivier Riou
Author Pascal Fenoglietto
Author Céline Bourgier
Author Olivier Lauche
Author Fatiha Boulbair
Author Marie Charissoux
Author Angélique Ducteil
Author Claire Lemanski
Author David Azria
Abstract BACKGROUND: Accelerated partial breast irradiation (APBI) is an option for adjuvant radiotherapy according to ASTRO and ESTRO recommendations. Among the available techniques, volumetric-modulated arc therapy (VMAT) is attractive but has not been extensively studied for APBI. This study assessed its feasibility, tolerance and early oncological outcomes. METHODS: We analysed the data of nine patients (median age 74 years) with ten lesions (one bilateral cancer) treated from May 2011 to July 2012 with APBI using VMAT. The radiation oncologist delineated the surgical tumour bed, and added an 18 mm isotropic margin to obtain the planning target volume (PTV). The dose was 40 Gy prescribed in 4 Gy fractions given twice a day over five days. Patients were regularly followed for toxicities and oncological outcomes. RESULTS: Mean PTV was 100.0 cm(3) and 95 % of the PTV received a mean dose of 99.7 % of the prescribed dose. Hot spots represented 0.3 % of the PTV. 6.2 %, 1.6 % and 0.3 % of the ipsilateral lung volume received 5 Gy (V5Gy), 10 Gy (V10Gy) and 20 Gy (V20Gy), respectively. Regarding the contralateral lung, V5Gy was 0.3 %, and V10Gy and V20Gy were nil. V5Gy accounted for 3.1 % of the heart. An average 580 monitor units were delivered. No acute or late grade???2 toxicities were observed. With a median follow-up of 26 months, no relapses occurred. CONCLUSION: In our study, VMAT allowed optimal dosimetry with consequential high therapeutic ratio in elderly and frail patients.
Publication Radiation Oncology (London, England)
Volume 10
Pages 209
Date Oct 14, 2015
Journal Abbr Radiat Oncol
Language eng
DOI 10.1186/s13014-015-0516-3
ISSN 1748-717X
Library Catalog PubMed
Extra PMID: 26466672 PMCID: PMC4606890
Tags Adult, Aged, Aged, 80 and over, Breast Neoplasms, clinic, Female, first-last-corresponding, Frail Elderly, Humans, Organs at Risk, Radiotherapy Dosage, Radiotherapy Planning, Computer-Assisted, Radiotherapy, Intensity-Modulated
Date Added 2019/05/28 - 22:10:56
Date Modified 2019/05/28 - 22:11:29
Notes and Attachments PubMed entry (Attachment)
Texte intégral (Attachment)


© Institut de Recherche en Cancérologie de Montpellier - 2011 - Tous droits réservés - Mentions légales - Connexion - Conception : ID Alizés